FRIENDLY CORPORATION Logo

FRIENDLY CORPORATION

Offers digital solutions for business growth: web production, marketing, e-commerce, & incubation.

8209 | T

Overview

Corporate Details

ISIN(s):
JP3829200009
LEI:
Country:
Japan
Address:
大東市寺川3丁目12番1号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Friendly Corporation is a creative company that provides comprehensive digital solutions to address corporate and social challenges. The firm specializes in a range of services designed to support business growth, including website production focused on brand storytelling and marketing outcomes. Its core offerings also encompass social media (SNS) and marketing consulting, advertising agency services, full-service e-commerce business support, and end-to-end new business incubation. The company partners with clients throughout the entire business lifecycle, from initial idea generation and strategic planning to product development, market entry, and acceleration.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-10 08:00
Report Publication Announcement
確認書
Japanese 8.7 KB
2025-11-10 08:00
Interim Report
半期報告書-第72期(2025/04/01-2026/03/31)
Japanese 214.9 KB
2025-06-30 03:26
Post-Annual General Meeting Information
臨時報告書
Japanese 23.4 KB
2025-06-27 05:01
Governance Information
内部統制報告書-第71期(2024/04/01-2025/03/31)
Japanese 23.1 KB
2025-06-27 05:00
Registration Form
有価証券報告書-第71期(2024/04/01-2025/03/31)
Japanese 760.7 KB
2025-06-27 05:00
Registration Form
確認書
Japanese 8.6 KB
2025-05-09 09:00
Regulatory News Service
臨時報告書
Japanese 18.3 KB
2025-04-14 04:08
Board/Management Information
臨時報告書
Japanese 20.6 KB
2025-02-10 08:00
Regulatory News Service
臨時報告書
Japanese 18.3 KB
2024-11-08 08:01
Regulatory News Service
臨時報告書
Japanese 18.2 KB
2024-11-08 08:00
Interim Report
確認書
Japanese 8.7 KB
2024-11-08 08:00
Interim Report
半期報告書-第51期(2024/04/01-2025/03/31)
Japanese 216.0 KB
2024-06-28 03:00
Regulatory News Service
訂正臨時報告書
Japanese 22.6 KB
2024-06-24 04:58
Post-Annual General Meeting Information
臨時報告書
Japanese 23.1 KB
2024-06-24 03:01
Regulatory News Service
臨時報告書
Japanese 18.1 KB

Automate Your Workflow. Get a real-time feed of all FRIENDLY CORPORATION filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for FRIENDLY CORPORATION

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for FRIENDLY CORPORATION via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

VALIRX PLC Logo
Advancing oncology & women's health therapeutics and offering preclinical research services.
United Kingdom
VAL
VALUE GOLF Inc. Logo
A golf services hub offering reservations, solo player bookings, e-commerce, lessons, and tours.
Japan
3931
Value HR Co., Ltd. Logo
Offers a health management platform and consulting for corporate health insurance societies in Japan.
Japan
6078
Global OTA for curated tours & experiences, focusing on travel to and from Japan.
Japan
7048
A South Korean travel company offering global tour packages, flights, hotels, and corporate travel.
South Korea
094850
Virax Biolabs Group Ltd Logo
Specializes in T-cell immunity tests and diagnostics for profiling viral disease responses.
United States of America
VRAX
VisionSys AI Inc Logo
Develops AI-powered brain-computer interfaces for the healthcare and biotech sectors.
United States of America
VSA
Vivesto Logo
Develops and licenses novel cancer therapies for humans and animals using proprietary drug delivery.
Sweden
VIVE
Vor Biopharma Inc. Logo
Clinical-stage biotech developing next-gen medicines that target the root cause of autoimmune disease.
United States of America
VOR
Voronoi, Inc. Logo
Develops selective kinase inhibitors and targeted protein degraders for precision oncology.
South Korea
310210

Talk to a Data Expert

Have a question? We'll get back to you promptly.